服务热线
021-60498804
产品中心
/ Products Classification 点击展开+Cat. Number | 070443143410131 |
||||||||||||||||||
Chemical Name | Hepsin Polyclonal Antibody (aa 241-260) |
||||||||||||||||||
References |
Background ReadingDhanasekaran, S.M., Barrette, T.R., Ghosh, D., et al. Delineation of prognostic biomarkers in prostate cancer. Nature 412 822-826 (2001). Kazama, Y., Hamamoto, T., Foster, D.C., et al. Hepsin, a putative membrane- Magee, J.A., Araki, T., Patil, S., et al. Expression profiling reveals hepsin overexpression in prostate cancer. Cancer Res 61 5692-5696 (2001). Tsuji, A., Torres-Rosado, A., Arai, T., et al. Hepsin, a cell membrane- Tanimoto, H., Yan, Y., Clarke, J., et al. Hepsin, a cell surface serine protease identified in hepatoma cells, is overexpressed in ovarian cancer. Cancer Res 57 2884-2887 (1997). Torres-Rosado, A., O'Shea, K.S., Tsuji, A., et al. Hepsin, a putative cell- Farley, D., Reymond, F., and Nick, H. Cloning and sequence analysis of rat hepsin, a cell surface serine proteinase. Biochim Biophys Acta 1173(3) 350-352 (1993). Leytus, S.P., Kurachi, K., Hagen, F.S., et al. A novel trypsin- Welsh, J.B., Sapinoso, L.M., Su, A.I., et al. Analysis of gene expression identifies candidate markers and pharmacological targets in prostate cancer. Cancer Res 61 5974-5978 (2001). Zacharski, L.R. Expression of the factor VII activating protease, hepsin, in situ in renal cell carcinoma. Thromb Haemost 79 876-877 (1998). Vu, T.H., Liu, R.W., Haaksman, C.J., et al. Identification and cloning of the membrane- Kawamura, S., Kurachi, S., Deyashiki, Y., et al. Complete nucleotide sequence, origin of isoform and functional characterization of the mouse hepsin gene. Eur J Biochem 262 755-764 (1999). Show all 12 Hide all but first 3
Description
Antigen:
human hepsin amino acids 241-
1
Tsuji, A., Torres-Rosado, A., Arai, T., et al. Hepsin, a cell membrane-
2
Leytus, S.P., Kurachi, K., Hagen, F.S., et al. A novel trypsin- 3 Dhanasekaran, S.M., Barrette, T.R., Ghosh, D., et al. Delineation of prognostic biomarkers in prostate cancer. Nature 412 822-826 (2001). 4 Magee, J.A., Araki, T., Patil, S., et al. Expression profiling reveals hepsin overexpression in prostate cancer. Cancer Res 61 5692-5696 (2001). 5 Welsh, J.B., Sapinoso, L.M., Su, A.I., et al. Analysis of gene expression identifies candidate markers and pharmacological targets in prostate cancer. Cancer Res 61 5974-5978 (2001). 6 Zacharski, L.R. Expression of the factor VII activating protease, hepsin, in situ in renal cell carcinoma. Thromb Haemost 79 876-877 (1998). 7 Tanimoto, H., Yan, Y., Clarke, J., et al. Hepsin, a cell surface serine protease identified in hepatoma cells, is overexpressed in ovarian cancer. Cancer Res 57 2884-2887 (1997).
8
Torres-Rosado, A., O'Shea, K.S., Tsuji, A., et al. Hepsin, a putative cell-
9
Kazama, Y., Hamamoto, T., Foster, D.C., et al. Hepsin, a putative membrane- |
||||||||||||||||||